Literature DB >> 32179137

Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).

Hiroshi Nishiura1, Tetsuro Kobayashi2, Takeshi Miyama3, Ayako Suzuki2, Sung-Mok Jung2, Katsuma Hayashi2, Ryo Kinoshita2, Yichi Yang2, Baoyin Yuan2, Andrei R Akhmetzhanov2, Natalie M Linton2.   

Abstract

Entities:  

Year:  2020        PMID: 32179137      PMCID: PMC7270890          DOI: 10.1016/j.ijid.2020.03.020

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


× No keyword cloud information.
The number of novel coronavirus (COVID-19) cases worldwide continues to grow, and the gap between reports from China and statistical estimates of incidence based on cases diagnosed outside China indicates that a substantial number of cases are underdiagnosed (Nishiura et al., 2020a). Estimation of the asymptomatic ratio—the percentage of carriers with no symptoms—will improve understanding of COVID-19 transmission and the spectrum of disease it causes, providing insight into epidemic spread. Although the asymptomatic ratio is conventionally estimated using seroepidemiological data (Carrat et al., 2008, Hsieh et al., 2014), the collection of these data requires significant logistical effort, time, and cost. Instead, we propose a method of estimating the asymptomatic ratio by using information on Japanese nationals who were evacuated from Wuhan, China on charter flights. Figure 1 illustrates the flow of the evacuation process. By February 6, 2020 a total of N = 565 citizens had been evacuated. Among them, pN = 63 (11.2%) were considered symptomatic upon arrival based on (1) temperature screening before disembarkation, and (2) face-to-face interviews eliciting information on symptoms including fever, cough, and other non-specific symptoms consistent with COVID-19. Reverse transcription PCR (RT-PCR) testing was performed for all passengers, and m = 4 asymptomatic and n = 9 symptomatic passengers tested positive for COVID-19.
Figure 1

Flow diagram of symptom screening and viral testing for passengers on chartered evacuation flights from Wuhan, China to Japan. The flow of Japanese residents evacuating from Wuhan and screened in Japan. A total of N passengers were evaluated, of whom a fraction p were symptomatic upon arrival. Among symptomatic and asymptomatic individuals, n and m persons, respectively, tested positive for the virus by RT-PCR.

Flow diagram of symptom screening and viral testing for passengers on chartered evacuation flights from Wuhan, China to Japan. The flow of Japanese residents evacuating from Wuhan and screened in Japan. A total of N passengers were evaluated, of whom a fraction p were symptomatic upon arrival. Among symptomatic and asymptomatic individuals, n and m persons, respectively, tested positive for the virus by RT-PCR. Employing a Bayes theorem, the asymptomatic ratio is defined aswhich can be calculated as m/(n + m), as seen in Figure 1. Using a binomial distribution, the asymptomatic ratio among evacuees was thus estimated to be 30.8% (95% confidence interval 7.7–53.8%). On March 6, 2020, a minimum of 30 days had elapsed since the citizens had departed from Wuhan – a length of observation sufficiently longer than the COVID-19 incubation period (Li et al., 2020, Linton et al., 2020). Thus, there was very little probability that the four virus-positive asymptomatic individuals would develop symptoms. In general, asymptomatic infections cannot be recognized if they are not confirmed by RT-PCR or other laboratory testing, and symptomatic cases may not be detected if they do not seek medical attention (Nishiura et al., 2020b). Estimates such as this therefore provide important insight by using a targeted population to assess the prevalence of asymptomatic viral shedding (Kupferschmidt and Cohen, 2020). It should be noted that the limited sensitivity of RT-PCR does not affect the estimate of the asymptomatic ratio, because the sensitivity is cancelled out from the right-hand side of the equation. However, a weakness of this study is that age-dependence and other aspects of heterogeneity were ignored, because the samples relied on Japanese evacuees from Wuhan. Despite the small sample size, this estimation indicates that perhaps less than a half of COVID-19-infected individuals are asymptomatic. This ratio is slightly smaller than that for influenza, which has been estimated at 56–80% (Hsieh et al., 2014) using similar definitions for symptomatic individuals. There is great need for further studies on the prevalence of asymptomatic COVID-19 infections to guide epidemic control efforts.

Ethical approval

Not required.

Conflict of interest

We declare that we have no conflict of interest.
  6 in total

1.  Time lines of infection and disease in human influenza: a review of volunteer challenge studies.

Authors:  Fabrice Carrat; Elisabeta Vergu; Neil M Ferguson; Magali Lemaitre; Simon Cauchemez; Steve Leach; Alain-Jacques Valleron
Journal:  Am J Epidemiol       Date:  2008-01-29       Impact factor: 4.897

2.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

3.  The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights.

Authors:  Hiroshi Nishiura; Tetsuro Kobayashi; Yichi Yang; Katsuma Hayashi; Takeshi Miyama; Ryo Kinoshita; Natalie M Linton; Sung-Mok Jung; Baoyin Yuan; Ayako Suzuki; Andrei R Akhmetzhanov
Journal:  J Clin Med       Date:  2020-02-04       Impact factor: 4.241

4.  Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.

Authors:  Natalie M Linton; Tetsuro Kobayashi; Yichi Yang; Katsuma Hayashi; Andrei R Akhmetzhanov; Sung-Mok Jung; Baoyin Yuan; Ryo Kinoshita; Hiroshi Nishiura
Journal:  J Clin Med       Date:  2020-02-17       Impact factor: 4.241

5.  The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020.

Authors:  Hiroshi Nishiura; Sung-Mok Jung; Natalie M Linton; Ryo Kinoshita; Yichi Yang; Katsuma Hayashi; Tetsuro Kobayashi; Baoyin Yuan; Andrei R Akhmetzhanov
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241

6.  Asymptomatic ratio for seasonal H1N1 influenza infection among schoolchildren in Taiwan.

Authors:  Ying-Hen Hsieh; Chen-An Tsai; Chien-Yu Lin; Jin-Hua Chen; Chwan-Chuen King; Day-Yu Chao; Kuang-Fu Cheng
Journal:  BMC Infect Dis       Date:  2014-02-12       Impact factor: 3.090

  6 in total
  444 in total

Review 1.  Epidemiological Measures in the Context of the COVID-19 Pandemic.

Authors:  Emilio Gianicolo; Nicola Riccetti; Maria Blettner; André Karch
Journal:  Dtsch Arztebl Int       Date:  2020-05-08       Impact factor: 5.594

2.  Reopening Schools After a Novel Coronavirus Surge.

Authors:  Dan Li; Elizabeth Z Lin; Marie A Brault; Julie Paquette; Sten H Vermund; Krystal J Godri Pollitt
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  The role of chest computed tomography in the management of COVID-19: A review of results and recommendations.

Authors:  Molly D Wong; Theresa Thai; Yuhua Li; Hong Liu
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-26

4.  Considerations in Upper Limb Rehabilitation during COVID-19 Crisis.

Authors:  Maryam Farzad; Mitra Ashrafi; Amir Reza Farhoud
Journal:  Arch Bone Jt Surg       Date:  2020-04

Review 5. 

Authors:  Paul Van Caeseele; Dana Bailey; Sarah E Forgie; Tanis C Dingle; Mel Krajden
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

Review 6.  Microfluidic-based approaches for COVID-19 diagnosis.

Authors:  Hsuan-Yu Mu; Yu-Lun Lu; Tzu-Hung Hsiao; Jen-Huang Huang
Journal:  Biomicrofluidics       Date:  2020-12-08       Impact factor: 2.800

7.  [Utility of preoperative polymerase chain reaction testing during SARS-CoV-2 pandemic: The challenge of evolving incidence].

Authors:  M de la Matta; J M Delgado-Sánchez; G M Gutiérrez; J L López Romero; M Del Mar Martínez Gómez; A Domínguez Blanco
Journal:  Rev Esp Anestesiol Reanim       Date:  2021-04-12

8.  Covert coronavirus infections could be seeding new outbreaks.

Authors:  Jane Qiu
Journal:  Nature       Date:  2020-03-20       Impact factor: 49.962

Review 9.  Reducing nosocomial transmission of COVID-19: implementation of a COVID-19 triage system.

Authors:  Rachel M Wake; Matthew Morgan; Jenny Choi; Simon Winn
Journal:  Clin Med (Lond)       Date:  2020-08-11       Impact factor: 2.659

10.  Novel Coronavirus Infection in Orthopedic Patients ; Report of Seven Cases.

Authors:  Hamid Rabie; Mohammad Hasan Sharafi; Leila Oryadi Zanjani; Mohammad Hossein Nabian
Journal:  Arch Bone Jt Surg       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.